Literature DB >> 2449803

Recurrent trigeminal cistern glycerol injections for tic douloureux.

Z H Rappaport1, J M Gomori.   

Abstract

Fourteen of 60 cases (23%) of trigeminal neuralgia underwent a repeat trigeminal cistern glycerol injection for recurrent pain. The mean time to recurrence was 14 months and the mean follow-up time following the last injection 10 months. Measurement of trigeminal cistern volume at the first and second procedure with metrizamide showed a significant decrease in the cistern volume from 0.38 ml to 0.29 ml. Clumping of nerve roots indicative of arachnoiditis was observed in 4 cases. In 2 further cases difficulty was encountered in emptying the cistern of metrizamide. After the repeat injection 2 patients developed painful dysethesia. Six patients showed either new or increased facial sensory deficits. These findings may indicate trigeminal cistern arachnoiditis. The possibility of deafferentation pain developing after trigeminal glycerol rhizolysis should prompt caution in the use of this technique in the younger patient.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2449803     DOI: 10.1007/bf01541263

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  15 in total

Review 1.  The treatment of trigeminal neuralgia (tic douloureux).

Authors:  W H Sweet
Journal:  N Engl J Med       Date:  1986-07-17       Impact factor: 91.245

Review 2.  Choice of surgical therapeutic modalities for treatment of trigeminal neuralgia: microvascular decompression, percutaneous retrogasserian thermal, or glycerol rhizotomy.

Authors:  L D Lunsford; R I Apfelbaum
Journal:  Clin Neurosurg       Date:  1985

3.  Trigeminal glycerol rhizolysis in the treatment of tic douloureux.

Authors:  Z H Rappaport; F Magora
Journal:  Eur J Anaesthesiol       Date:  1985-03       Impact factor: 4.330

4.  Treatment of tic douloureux by percutaneous retrogasserian glycerol injection.

Authors:  L D Lunsford
Journal:  JAMA       Date:  1982-07-23       Impact factor: 56.272

5.  Trigeminal cistern glycerol injections for facial pain.

Authors:  T A Waltz; D J Dalessio; K H Ott; B Copeland; G Abbott
Journal:  Headache       Date:  1985-10       Impact factor: 5.887

6.  Treatment of trigeminal neuralgia and other facial pains by retrogasserian injection of glycerol.

Authors:  W H Sweet; C E Poletti; J B Macon
Journal:  Neurosurgery       Date:  1981-12       Impact factor: 4.654

7.  Percutaneous retrogasserian glycerol rhizotomy for tic douloureux: Part 1. Technique and results in 112 patients.

Authors:  L D Lunsford; M H Bennett
Journal:  Neurosurgery       Date:  1984-04       Impact factor: 4.654

8.  Success of microvascular decompression with and without prior surgical therapy for trigeminal neuralgia.

Authors:  D Barba; J F Alksne
Journal:  J Neurosurg       Date:  1984-01       Impact factor: 5.115

9.  Percutaneous retrogasserian glycerol rhizotomy for trigeminal neuralgia. A prospective study of 100 cases.

Authors:  M J Arias
Journal:  J Neurosurg       Date:  1986-07       Impact factor: 5.115

10.  Percutaneous retrogasserian glycerol rhizotomy for treatment of trigeminal neuralgia.

Authors:  D W Beck; J J Olson; E J Urig
Journal:  J Neurosurg       Date:  1986-07       Impact factor: 5.115

View more
  3 in total

1.  Long-term results after percutaneous retrogasserian glycerol rhizotomy in patients with trigeminal neuralgia.

Authors:  H Slettebø; H Hirschberg; K F Lindegaard
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

Review 2.  The leptomeninges as a critical organ for normal CNS development and function: First patient and public involved systematic review of arachnoiditis (chronic meningitis).

Authors:  Carol S Palackdkharry; Stephanie Wottrich; Erin Dienes; Mohamad Bydon; Michael P Steinmetz; Vincent C Traynelis
Journal:  PLoS One       Date:  2022-09-30       Impact factor: 3.752

3.  Percutaneous Procedures for Trigeminal Neuralgia.

Authors:  Kyung Won Chang; Hyun Ho Jung; Jin Woo Chang
Journal:  J Korean Neurosurg Soc       Date:  2022-06-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.